| A guide to the composition and functions of the extracellular matrix NK Karamanos, AD Theocharis, Z Piperigkou, D Manou, A Passi, ... The FEBS journal 288 (24), 6850-6912, 2021 | 648 | 2021 |
| Hyaluronan: molecular size‐dependent signaling and biological functions in inflammation and cancer AG Tavianatou, I Caon, M Franchi, Z Piperigkou, D Galesso, ... The FEBS journal 286 (15), 2883-2908, 2019 | 374 | 2019 |
| Proteoglycan chemical diversity drives multifunctional cell regulation and therapeutics NK Karamanos, Z Piperigkou, AD Theocharis, H Watanabe, M Franchi, ... Chemical reviews 118 (18), 9152-9232, 2018 | 322 | 2018 |
| Protein bio-corona: critical issue in immune nanotoxicology M Neagu, Z Piperigkou, K Karamanou, AB Engin, AO Docea, ... Archives of toxicology 91, 1031-1048, 2017 | 239 | 2017 |
| Estrogen receptor alpha mediates epithelial to mesenchymal transition, expression of specific matrix effectors and functional properties of breast cancer cells P Bouris, SS Skandalis, Z Piperigkou, N Afratis, K Karamanou, AJ Aletras, ... Matrix Biology 43, 42-60, 2015 | 198 | 2015 |
| Emerging aspects of nanotoxicology in health and disease: from agriculture and food sector to cancer therapeutics Z Piperigkou, K Karamanou, AB Engin, C Gialeli, AO Docea, DH Vynios, ... Food and Chemical Toxicology 91, 42-57, 2016 | 116 | 2016 |
| Shed proteoglycans in tumor stroma Z Piperigkou, B Mohr, N Karamanos, M Götte Cell and tissue research 365, 643-655, 2016 | 95 | 2016 |
| Estrogen receptor beta modulates breast cancer cells functional properties, signaling and expression of matrix molecules Z Piperigkou, P Bouris, M Onisto, M Franchi, D Kletsas, AD Theocharis, ... Matrix Biology 56, 4-23, 2016 | 92 | 2016 |
| Extracellular matrix-based cancer targeting NK Karamanos, Z Piperigkou, A Passi, M Götte, P Rousselle, I Vlodavsky Trends in molecular medicine 27 (10), 1000-1013, 2021 | 88 | 2021 |
| Key matrix remodeling enzymes: functions and targeting in cancer Z Piperigkou, K Kyriakopoulou, C Koutsakis, S Mastronikolis, ... Cancers 13 (6), 1441, 2021 | 80 | 2021 |
| Lumican effectively regulates the estrogen receptors-associated functional properties of breast cancer cells, expression of matrix effectors and epithelial-to-mesenchymal … K Karamanou, M Franchi, Z Piperigkou, C Perreau, FX Maquart, ... Scientific reports 7 (1), 45138, 2017 | 76 | 2017 |
| Strategies to target matrix metalloproteinases as therapeutic approach in cancer Z Piperigkou, D Manou, K Karamanou, AD Theocharis Proteases and cancer: methods and protocols, 325-348, 2018 | 72 | 2018 |
| Evaluation of the coordinated actions of estrogen receptors with epidermal growth factor receptor and insulin‐like growth factor receptor in the expression of cell surface … AI Tsonis, N Afratis, C Gialeli, MI Ellina, Z Piperigkou, SS Skandalis, ... The FEBS journal 280 (10), 2248-2259, 2013 | 69 | 2013 |
| Insights into the key roles of epigenetics in matrix macromolecules-associated wound healing Z Piperigkou, M Götte, AD Theocharis, NK Karamanos Advanced drug delivery reviews 129, 16-36, 2018 | 66 | 2018 |
| Extracellular matrix-mediated breast cancer cells morphological alterations, invasiveness, and microvesicles/exosomes release M Franchi, Z Piperigkou, KA Karamanos, L Franchi, V Masola Cells 9 (9), 2031, 2020 | 55 | 2020 |
| Estrogen receptor-mediated targeting of the extracellular matrix network in cancer Z Piperigkou, NK Karamanos Seminars in cancer biology 62, 116-124, 2020 | 51 | 2020 |
| Dynamic interplay between miRNAs and the extracellular matrix influences the tumor microenvironment Z Piperigkou, NK Karamanos Trends in biochemical sciences 44 (12), 1076-1088, 2019 | 51 | 2019 |
| Estrogen receptor beta as epigenetic mediator of miR-10b and miR-145 in mammary cancer Z Piperigkou, M Franchi, M Goette, NK Karamanos Matrix Biology 64, 94-111, 2017 | 51 | 2017 |
| Epigenetic alterations in triple-negative breast cancer—the critical role of extracellular matrix V Zolota, V Tzelepi, Z Piperigkou, H Kourea, E Papakonstantinou, ... Cancers 13 (4), 713, 2021 | 49 | 2021 |
| Advances in targeting epidermal growth factor receptor signaling pathway in mammary cancer K Kyriakopoulou, E Kefali, Z Piperigkou, H Bassiony, NK Karamanos Cellular Signalling 51, 99-109, 2018 | 46 | 2018 |
Nikos KaramanosProfessor of Biochemistry, University of Patras, Department of Chemistry, GreeceVerified email at upatras.gr
